A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn (Q37429296)
Jump to navigation
Jump to search
scientific article published on September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn |
scientific article published on September 2009 |
Statements
1 reference
A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn (English)
1 reference
Jean-Pierre Després
1 reference
Josep Rodés-Cabau
1 reference
Olivier F Bertrand
1 reference
Paul Poirier
1 reference
Stéphane Rinfret
1 reference
Lawrence Title
1 reference
Vladimir Dzavik
1 reference
Madhu Natarajan
1 reference
Juan Angel
1 reference
Nuria Batalla
1 reference
Natalie Alméras
1 reference
Olivier Costerousse
1 reference
Robert De Larochellière
1 reference
Louis Roy
1 reference
VICTORY trial investigators
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference